Codagenix CEO, J. Robert Coleman, will be presenting at “The Quest for a COVID-19 Vaccine” webinar hosted by the National Academy of Sciences. Please join to hear the latest news in the development of Codagenix’s single dose, intranasal vaccine against COVID-19.

Register here for the Feb 2, 2021 webinar.